(Q48183064)

9 February 2018

title

Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia (English)

1 reference

9 February 2018

1 reference

1 reference

Jolkkonen J

1

1 reference

9 February 2018

Puurunen K

2

1 reference

9 February 2018

Koistinaho J

3

1 reference

9 February 2018

Kauppinen R

4

1 reference

9 February 2018

Haapalinna A

5

1 reference

9 February 2018

Nieminen L

6

1 reference

9 February 2018

Sivenius J

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 February 2018

European Journal of Pharmacology

published in

1 reference

9 February 2018

volume

372

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

31-36

1 reference

9 February 2018

Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Prophylactic neuroprotection for cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Cerebrovascular disease and functional outcome after coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Hyperglycemia and the vascular effects of cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Reversible middle cerebral artery occlusion without craniectomy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Morphometric evaluation of brain infarcts in rats and gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

The alpha 2 adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Anticonvulsant effects of clonidine mediated through central alpha2-adrenoceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

A semiautomated method for measuring brain infarct volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Glucose modulation of ischemic brain injury: review and clinical recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

Dexmedetomidine Improves Neurologic Outcome from Incomplete Ischemia in the Rat Reversal by the α2-Adrenergic Antagonist Atipamezole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Graded Hypotension and MCA Occlusion Duration: Effect in Transient Focal Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900186-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00186-7

1 reference

9 February 2018

release_pbpsvdplundoxnwm34v7p77fde

Fatcat ID

0 references

1 reference

9 February 2018